chevron_leftBack
As of 5 June 2026, The Calmer Co International Ltd. has a market cap of $6.28M USD, ranking #43533 globally and #1489 in Australia.
It ranks #3863 in the Healthcare sector, and #1242 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$6.28MUSD
8.8M AUD
Enterprise Value
$8.16MUSD
11.44M AUD
Revenue (TTM)
$5.78MUSD
8.1M AUD
EBITDA (TTM)
-$1.92MUSD
-2.69M AUD
Net Income (TTM)
-$2.41MUSD
-3.37M AUD
EBITDA Margin
-33%
Profit Margin
-42%
PS Ratio
1.1
PB Ratio
47.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Zane Yoshida
open_in_new
Founded
2014
Website
thecalmerco.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -20% | -20% | -33% | -60% | -50% | -50% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
CCO
The Calmer Co International Ltd Ordinary Shares
ISIN: AU0000275216
Shares Out.:
Shares Outstanding:
3.521B1
Shares Float:
3.511B2
|
0.0020 AUD | |
|
CCOR
ISIN: AU0000391997
|
0.0010 AUD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About The Calmer Co International Ltd.
The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, New Zealand, the United States, and internationally. It produces and sells powdered drinking kava, teas, and capsules under the FijiKava brand name; flavoured and non-flavoured kava shots, tinctures, and traditional and instant drinking kava under the Taki Mai brand name; hemp, CBD oils, topical salves, and pet CBD oils under Danodan brand name. In addition, it sells its products through retailers and online. The company was formerly known as Fiji Kava Limited and changed its name to The Calmer Co International Limited in April 2023. The Calmer Co International Limited was incorporated in 2014 and is based in Yeronga, Australia.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
ASX: SIG
|
$22.82B
363K%
31.98B AUD
|
52.3
|
|
ASX: PYC
|
$926.22M
15K%
1.3B AUD
|
-
|
|
ASX: RAC
|
$346.24M
5K%
485.18M AUD
|
-
|
|
ASX: CUV
|
$335.4M
5K%
469.99M AUD
|
14.5
|
|
ASX: SPL
|
$216.39M
3K%
303.23M AUD
|
-
|
|
ASX: MYX
|
$166.4M
3K%
233.18M AUD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
12M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
9M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
6M%
|
97.4
|
|
SIX: RO
|
$324.68B
5M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.25B
5M%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
4M%
218.9B CHF
|
20.5
|
chevron_leftBack